Hasil Pencarian - Kim Rand
- Menampilkan 1 - 19 hasil dari 19
-
1
-
2
Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L oleh Kim Rand, Espen Ajo Arnevik, Espen Walderhaug
Diterbitkan 2020-11-01Dapatkan teks lengkap
Artikel -
3
-
4
-
5
-
6
-
7
General population norms for the EQ-5D-3 L in Norway: comparison of postal and web surveys oleh Knut Stavem, Liv A Augestad, Ivar S Kristiansen, Kim Rand
Diterbitkan 2018-10-01Dapatkan teks lengkap
Artikel -
8
194:oral Severity and EQ-5D: when health state value and moral value differ oleh Mathias Barra, Kim Rand, Marius L Torjusen, David Whitehurst, Liv Augestad
Diterbitkan 2022-04-01Artikel -
9
Reduced quality of life, more technical challenges, and less study motivation among paramedic students after one year of the COVID-19 pandemic – a survey study oleh Kristin Häikiö, Astrid Karina Harring, Rune Kveen, Kim Rand, Trine Møgster Jørgensen
Diterbitkan 2023-03-01Dapatkan teks lengkap
Artikel -
10
A retrospective survey study of paramedic students’ exposure to SARS-CoV-2, participation in the COVID-19 pandemic response, and health-related quality of life oleh Kristin Häikiö, Jeanette V. Andersen, Morten Bakkerud, Carl R. Christiansen, Kim Rand, Trine Staff
Diterbitkan 2021-10-01Dapatkan teks lengkap
Artikel -
11
Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol oleh Knut Stavem, Tonya Moen Hansen, Ylva Helland, Liv Ariane Augestad, Kim Rand, Andrew Garratt
Diterbitkan 2020-06-01Dapatkan teks lengkap
Artikel -
12
Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Mo... oleh Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José-Carlos Armario-Hita
Diterbitkan 2024-03-01Dapatkan teks lengkap
Artikel -
13
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis oleh Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José-Carlos Armario-Hita
Diterbitkan 2023-10-01Dapatkan teks lengkap
Artikel -
14
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Der... oleh Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José-Carlos Armario-Hita
Diterbitkan 2024-01-01Dapatkan teks lengkap
Artikel -
15
-
16
Evaluación de los resultados en salud del implante valvular aórtico transcatéter en una cohorte de pacientes según su perfil de riesgo oleh Eduardo Pinar, Juan García de Lara, José Hurtado, Miguel Robles, Gunnar Leithold, Belén Martí-Sánchez, Paloma González, Kim Rand, Jesús Cuervo
Diterbitkan 2023-05-01Dapatkan teks lengkap
Artikel -
17
Prospective assessment of clinical outcomes of transcatheter aortic valve implantation in a cohort of patients based on their risk profile oleh Eduardo Pinar, Juan García de Lara, José Hurtado, Miguel Robles, Gunnar Leithold, Belén Martí-Sánchez, Paloma González, Kim Rand, Jesús Cuervo
Diterbitkan 2023-05-01Dapatkan teks lengkap
Artikel -
18
Digital thErapy For Improved tiNnitus carE Study (DEFINE): Protocol for a randomised controlled trial. oleh Matthew E Smith, Dhiraj Sharma, Oliver Rivero-Arias, Kim Rand, Lucy Barrack, Emma Ogburn, Michael Young, Polly Field, Jan Multmeier, Jameel Muzaffar
Diterbitkan 2024-01-01Dapatkan teks lengkap
Artikel -
19